GLP-1 Supplements False Advertising Investigation
Case Overview
The investigation centers on supplement companies that may have marketed GLP-1 supplements, also known as nutraceuticals, with misleading claims. These products are advertised as offering weight loss or appetite suppression effects comparable to prescription GLP-1 medications, even though they are not the same as those prescription drugs.
The claims being investigated allege that companies used false or deceptive advertising to promote these supplements' effectiveness. Consumers who purchased these products based on these misleading claims may have suffered financial harm.
California residents who purchased a GLP-1 alternative based on these advertising claims may qualify to participate in the investigation. Interested individuals are advised to fill out a form on the page to determine their eligibility for a free case evaluation.
Who May Qualify
California residents who purchased a GLP-1 supplement or nutraceutical advertised to help with weight loss or appetite suppression within the past 3 years.